Beside the main observations regarding severe hypoglycemia reviewed above, there were other notable findings.
In comparison with HIF-1, which is activated over a wide range of oxygen concentrations of around 2%, maximum activation of the UPR requires exposure to more severe hypoxia (reviewed in [ 49]).
It is well accepted that proinflammatory cytokines such as TNF and IL-1 play an important role, and administration of TNF antagonists is an effective treatment for severe RA (reviewed in [ 9]).
Although a number of well-designed, randomized, controlled trials failed to show any benefits of steroid therapy in terms of improved survival in patients with severe sepsis (reviewed in [ 37, 38]), with mortality increased in many as a result of an increased incidence of nosocomial infections, these trials were primarily investigating the efficacy of short courses of high-dose steroids.
The objective of this study was to determine whether emergency physicians who have specific training in ultrasonography could identify severe AS on review of only the PSLA and PSSA B-mode echocardiography images.
In the case of a resuscitation protocol for patients with severe sepsis, the review must examine the supportive evidence for each of the component parts.
Contrary to this, anti-TNF monoclonal antibody and IL-1 receptor antagonist failed to benefit patients with severe sepsis (for review [ 13]).
Where outcomes were not included in this review (severe PPH, need for blood transfusion), results were generated for the analyses presented here based on the studies included in the review using the random effects model in StatsDirect (Version 2.7.8, 2010) [ 24– 26].
For the purpose of this systematic review, severe TBI is defined as 'a brain injury incurred by a traumatic mechanism of injury with a resultant level of consciousness categorised by a Glasgow Coma Scale (GCS) score of 8 or lower' [ 3].
The striking loss of VGLUT2 diffuse labeling observed in the IML of the DG at 12 months after pilocarpine treatment is likely to reflect further degeneration of mossy cells including those from the ventral DG observed in epileptic animals experiencing severe seizures (for review see Kienzler et al. 2009) as well as in patients suffering from mesial temporal lobe epilepsy (Blümcke et al. 2000).
